Product Name:Raltegravir
CAS: 518048-05-0
MF: C20H21FN6O5
MW:444.42
Product Categories: Inhibitors;Isentress;API;518048-05-0
Mol File: 518048-05-0.mol
Structure:
|
Test Items |
Specification |
|
Appearance |
White or off-white powder |
|
Related substances
|
Total impurities ≤1.0% |
|
Max unknown single impurity ≤0.5% |
|
|
Water |
≤1.0% |
|
Residue on ignition |
≤0.1% |
|
Assay |
≥99.0% |
Usage:Raltegravir is an antiretroviral medication primarily used for the treatment of human immunodeficiency virus (HIV) infection. It belongs to the class of integrase strand transfer inhibitors, which work by inhibiting the virus’s ability to integrate its genetic material into host cells, thus helping to suppress HIV replication and propagation. This medication is commonly used for the treatment of HIV infection, especially in patients who have developed resistance to other antiretroviral drugs. Please note that the specific dosage and administration of the drug should be followed according to the guidance of healthcare professionals and prescription.
